Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents Over Three Decades, 1995-2017: Cross-Sectional Analysis

Audrey D Zhang, Jeremy Puthumana, Nicholas S Downing, Nilay D Shah, View ORCID ProfileHarlan M Krumholz, View ORCID ProfileJoseph S Ross
doi: https://doi.org/10.1101/19007047
Audrey D Zhang
1New York University School of Medicine, New York, NY, USA
2Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USA
Roles: Medical Student
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy Puthumana
3Yale School of Medicine, New Haven, CT, USA
Roles: Medical Student
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas S Downing
4Bain Capital, Boston, MA, USA
Roles: Associate
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nilay D Shah
5Division of Health Care Policy and Research and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA
Roles: Associate Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harlan M Krumholz
2Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USA
6Section of Cardiovascular Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven CT, USA
7Department of Health Policy and Management, Yale School of Public Health, New Haven CT, USA
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Harlan M Krumholz
Joseph S Ross
2Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USA
7Department of Health Policy and Management, Yale School of Public Health, New Haven CT, USA
8Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven CT, USA
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joseph S Ross
  • For correspondence: joseph.ross{at}yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

  • Supplemental Material
  • Research Checklist
Back to top
PreviousNext
Posted September 23, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents Over Three Decades, 1995-2017: Cross-Sectional Analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents Over Three Decades, 1995-2017: Cross-Sectional Analysis
Audrey D Zhang, Jeremy Puthumana, Nicholas S Downing, Nilay D Shah, Harlan M Krumholz, Joseph S Ross
medRxiv 19007047; doi: https://doi.org/10.1101/19007047
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents Over Three Decades, 1995-2017: Cross-Sectional Analysis
Audrey D Zhang, Jeremy Puthumana, Nicholas S Downing, Nilay D Shah, Harlan M Krumholz, Joseph S Ross
medRxiv 19007047; doi: https://doi.org/10.1101/19007047

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Policy
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)